E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Obesity > Why It Doesn't Pay To Be Overweight

Tags

  • involved
  • being
  • drugs
  • excess weight
  • excess weight
  • combination products

  • Links

  • Finding Valuable Cancer Information
  • 7 Tips for Success
  • Consulting - How To Be Successful
  • E-Articles - Why It Doesn't Pay To Be Overweight

    Being overweight reaches beyond personal appearance and pride. If you are overweight, you are likely to trigger or worsen any number of healt
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    h problems. Obesity is now thought to be as big a cause of ill-health as smoking!

    I have listed the major health problems associated with be
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ng obese or overweight. Its important to remember that I am not saying you will have these problems. Rather, your chances of having at least
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ne significantly increase the more excess weight you carry.
    1. Heart disease and stroke

      Heart disease and stroke ar
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    the leading causes of death and disability in the western world. Being overweight increases your chances of angina and sudden death from hea
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    t disease and stroke. Recent research suggests that if your waist size is above 35 inches your risk of heart disease is high.
  • ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ng>High blood pressure

    High blood pressure rarely makes you feel ill. That is not to say its harmless. It can lead to heart disease
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    Being overweight is one of the causes of high blood pressure.
  • Diabetes

    Noninsulin-dependent diabetes (Type 2 dia
  • nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    etes) is the most common type of diabetes. About 8 in 10 people diagnosed with Type 2 diabetes are overweight. Carrying extra weight may caus
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    the insulin the body produces to work less effectively. This makes diabetes more likely to develop. The effect is more severe if the excess
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    eight is around the waist. One of the most serious long term risks of diabetes is cardiovascular disease.
  • Cancer

  • ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    Cancers of the colon, breast (postmenopausal), endometrium (the lining of the uterus), cervix, gall bladder, and ovary are associated with ob
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    sity in women. Overweight men are at greater risk of developing prostate cancer, cancer of the colon, and cancer of the rectum.

    In 2002, it
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    as estimated that approximately 3% of all new cancers are linked with obesity. A recent study estimated that, in the United States, 14 percen
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    of deaths from cancer in men and 20 percent of deaths in women were due to overweight.
  • Snoring and sleep apnea

    S
  • t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    eep apnea causes a person to stop breathing for short periods during sleep. It can also cause daytime sleepiness. The more overweight you are
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    , the greater the risk of developing sleep apnea.
  • Osteoarthritis

    This joint disorder normally affects joints in y
  • y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ur knees, hips, and lower back. The extra weight increases the risk of osteoarthritis. The excess weight is thought to wear away the protecti
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    e cartilage from the joints.

    You also increase the risk of the following if you are overweight:
    • Stress, anxiety, and depr
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ssion
  • Gout
  • Vaginal prolapse of the rectum, womb, and/or bladder.
  • Poor recovery from medical operations


  • tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/261423/e-article-Why-It-Doesnt-Pay-To-Be-Overweight.html">Why It Doesn't Pay To Be Overweight</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/261423/e-article-Why-It-Doesnt-Pay-To-Be-Overweight.html]Why It Doesn't Pay To Be Overweight[/url]

    Related Articles:

    Effective Communications In Our Digital World

    God's Breathed

    How Diet Can Relieve IBS Symptoms

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com